AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 45 filers reported holding AEVI GENOMIC MEDICINE INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $43,000 | -69.9% | 61,223 | -47.3% | 0.00% | – |
| Q3 2018 | $143,000 | +130.6% | 116,199 | +107.5% | 0.00% | – |
| Q2 2018 | $62,000 | -54.7% | 55,991 | -18.0% | 0.00% | – |
| Q1 2018 | $137,000 | +31.7% | 68,248 | -21.3% | 0.00% | – |
| Q4 2017 | $104,000 | -36.2% | 86,703 | -33.1% | 0.00% | – |
| Q3 2017 | $163,000 | -27.6% | 129,559 | -23.4% | 0.00% | – |
| Q2 2017 | $225,000 | -28.3% | 169,222 | +0.1% | 0.00% | -100.0% |
| Q1 2017 | $314,000 | -83.3% | 169,040 | -53.4% | 0.00% | -75.0% |
| Q4 2016 | $1,879,000 | – | 362,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|